# Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use

> **NCT00876941** · PHASE3 · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 589 (actual)

## Conditions studied

- Drug Usage
- Drug Abuse
- Drug Dependence

## Interventions

- **BEHAVIORAL:** Standard Brief Intervention
- **BEHAVIORAL:** Enhanced Brief Intervention
- **BEHAVIORAL:** Control: Information and Feedback

## Key facts

- **NCT ID:** NCT00876941
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-10
- **Final completion:** 2014-09
- **Target enrollment:** 589 (ACTUAL)
- **Last updated:** 2014-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876941, "Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00876941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*